Rocket Pharmaceuticals Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5.4% | -11.8% | -10.6% | -11.8% | +34.0% | -10.7% | -10.6% | -12.6% | -10.2% | -13.6% | +48.2% | |
| – | -15.4% | -8.7% | -15.2% | -17.4% | +56.4% | -14.2% | -14.6% | -17.9% | -15.3% | -22.3% | +93.3% | |
| – | -75.2% | -36.9% | +9.4% | +69.9% | +149.4% | -69.6% | -34.1% | +131.4% | +2.1% | -36.0% | +352.5% | |
| – | -14.6% | -11.5% | -15.6% | -15.5% | +58.0% | -14.5% | -14.7% | -18.0% | -15.2% | -23.6% | +96.5% | |
| – | – | – | -5.8% | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | +27.9% | -21.5% | +6.6% | +3.5% | +0.9% | -8.6% | +13.3% | -18.6% | -2.1% | -11.0% | +14.6% | |
| – | +44.9% | -32.1% | +14.1% | +6.4% | +1.8% | -13.2% | +22.9% | -28.2% | -3.1% | -19.0% | +28.0% | |
| – | -4.8% | +5.7% | -0.5% | -0.4% | +0.4% | +0.7% | +0.6% | +0.6% | +0.1% | +0.3% | +1.9% | |
| – | -99.9% | +155,148.3% | +11.3% | -9.5% | -41.3% | +81.2% | -42.0% | +56.4% | – | – | +571.1% | |
| – | -9.0% | -10.4% | -12.9% | -14.3% | +40.5% | -11.0% | -14.1% | -11.4% | -11.6% | -14.1% | +54.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.7% | +11.4% | +0.2% | +0.4% | +3.6% | +12.9% | +0.8% | +0.5% | -0.4% | +0.9% | +2.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.